Starpharma (ASX:SPL) report their revenue is up 142 per cent to $6.56 million.
The increase in revenue reflects the AstraZeneca $4.3 million development milestone.
The company still reported loss after tax is $14.7 million from the expense of all research and development expenditure and patenting costs associated with VivaGel® and DEP® programs.
Shares in Starpharma (ASX:SPL) are trading 5.6 per cent higher at $1.41.
24 Aug 2020 - Property agency McGrath (ASX:MEA) has seen a turnaround in its fortunes with net profit swinging from a $9.7 million loss in FY19 to $700 000 this financial year.
Earnings of $3.7 were up $10.1 million from a loss of $6.4 million last financial year.
30 Dec 2019 - Wastewater management company, Fluence Corporation (ASX:FLC) has secured a follow-on order for Aspiral from Aerospace Kaitian Environmental Technology.
12 Nov 2019 - Legal proceedings in New Zealand against BlueScope (ASX:BSL) subsidiary, Toward Industries Limited, were discontinued yesterday by New Zealand Iron Sands Holdings Limited (NZIS).
26 Nov 2020 - Gentrack Group Limited (ASX:GTK) report results for the year show underlying EBITDA of $12.1 million, down 51 per cent on FY19, off the back of lower FY20 revenues coming in at $100.5 million, a 10 per cent decrease on FY19.
02 Dec 2020 - Mesoblast (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for remestemcel-L in the treatment of acute respiratory distress syndrome (ARDS) due to Covid-19 infection..
